Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia

Cited by papers we hold 4

• Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications · 2023
  No notice
• Expression patterns of immune checkpoints in acute myeloid leukemia · 2020
  No notice
• The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017 · 2020
  No notice
• New directions for emerging therapies in acute myeloid leukemia: the next chapter · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.